
Dormosedan® (detomidine hydrochloride) is an FDA-approved preparation containing detomidine hydrochloride, for veterinary use. Available by prescription.
Veterinarians most commonly consider detomidine when the clinical objective is profound sedation and localized tissue management during procedures that require the horse to remain standing but stationary. It is frequently a point of discussion for diagnostic imaging, dental work, wound repair and as a pre-anesthetic agent before general anesthesia. By modulating specific receptors in the central nervous system, veterinarians can manage the patient’s physiological response to environmental stimuli and physical handling.
At a pharmacological level, detomidine acts by stimulating alpha-2 adrenoceptors located in the brain and spinal cord. This stimulation inhibits the release of norepinephrine, a key neurotransmitter involved in maintaining alertness and mediating the stress response. The resulting neurochemical shift leads to dose-dependent sedation, muscle relaxation and visceral analgesia. Detomidine is known for its high affinity for these receptors, which contributes to its potency and the duration of its physiological effects. Your veterinarian will determine whether detomidine is appropriate for your horse based on weight, age, cardiovascular status and the specific nature of the prescriptions required for the intended procedure.
The actions described here reflect the product's FDA-approved labeling; your veterinarian determines the appropriate use for your animal.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring.
Commonly observed effects of detomidine administration include a significant decrease in heart rate (bradycardia), initial hypertension followed by a decrease in blood pressure and a drop in body temperature. Horses often exhibit a characteristic "low-head" posture, drooping of the lower lip and partial protrusion of the penis in males. Some animals may experience transient sweating, piloerection (hair standing up) or increased urine production. Because detomidine has a profound effect on cardiovascular health, your veterinarian will monitor the horse’s vital signs closely throughout the duration of sedation.
This medication is typically used with extra caution or avoided in horses with known cardiovascular disease, respiratory impairment, kidney or liver dysfunction, shock or severe dehydration. It is also carefully evaluated in geriatric animals or those receiving certain other medications, as alpha-2 agonists can interact with other central nervous system depressants. Owners should be aware that sedated horses can still react to sudden noises or physical touch; therefore, a quiet environment is often recommended during the recovery period. Contact your veterinarian promptly if you observe any unexpected changes or prolonged lethargy after the sedative effects should have diminished.
Yes. Detomidine hydrochloride is a potent prescription sedative and can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped.
Yes. While detomidine is available as a commercial injectable and an oromucosal gel, Mixlab can compound this medication into specialized strengths or alternative formats if your veterinarian determines a customized preparation better suits an individual patient's clinical needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
A low-head carriage is a commonly observed physiological response to detomidine as the medication induces deep sedation and muscle relaxation. Your veterinarian monitors this posture as part of the assessment of the sedation level to ensure the horse is ready for the planned procedure.
The duration of the sedative effects is typically dose-dependent and can be influenced by the horse's individual metabolism and the route of administration. Your veterinarian will provide guidance on the expected recovery time and when it is safe to resume normal feeding and activity.




